Drug Information
Drug (ID: DG00413) and It's Reported Resistant Information
Name |
Quinolones
|
||||
---|---|---|---|---|---|
Synonyms |
AC1MI0KP
Click to Show/Hide
|
||||
Indication |
In total 2 Indication(s)
|
||||
Structure | |||||
Drug Resistance Disease(s) |
Disease(s) with Clinically Reported Resistance for This Drug
(1 diseases)
Staphylococcus meningitis [ICD-11: 1B54]
[1]
|
||||
Target | DNA topoisomerase II (TOP2) |
TOP2A_HUMAN
; TOP2B_HUMAN |
[1] | ||
Click to Show/Hide the Molecular Information and External Link(s) of This Drug | |||||
Formula |
C9H7NO
|
||||
IsoSMILES |
C1=CC=C2C(=C1)C=CC(=O)N2
|
||||
InChI |
1S/C9H7NO/c11-9-6-5-7-3-1-2-4-8(7)10-9/h1-6H,(H,10,11)
|
||||
InChIKey |
LISFMEBWQUVKPJ-UHFFFAOYSA-N
|
||||
PubChem CID | |||||
ChEBI ID | |||||
TTD Drug ID |
Type(s) of Resistant Mechanism of This Drug
IDUE: Irregularity in Drug Uptake and Drug Efflux
UAPP: Unusual Activation of Pro-survival Pathway
Drug Resistance Data Categorized by Their Corresponding Diseases
ICD-01: Infectious/parasitic diseases
Staphylococcus meningitis [ICD-11: 1B54]
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Key Molecule: Quinolone resistance protein NorB (NORB) | [1] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Disease | Staphylococcus aureus infection [ICD-11: 1B54.0] | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Escherichia coli | 668369 | ||
Experiment for Molecule Alteration |
DNA microarray hybridization assay | |||
Experiment for Drug Resistance |
Serial twofold agar dilutions assay | |||
Mechanism Description | MgrA was an indirect regulator of norB expression. The mgrA norB double mutant was reproducibly twofold more susceptible to the tested quinolones than the mgrA mutant. | |||
Unusual Activation of Pro-survival Pathway (UAPP) | ||||
Key Molecule: HTH-type transcriptional regulator MgrA (MGRA) | [1] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Disease | Staphylococcus aureus infection [ICD-11: 1B54.0] | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Escherichia coli | 668369 | ||
Experiment for Molecule Alteration |
DNA microarray hybridization assay | |||
Experiment for Drug Resistance |
Serial twofold agar dilutions assay | |||
Mechanism Description | MgrA was an indirect regulator of norB expression. The mgrA norB double mutant was reproducibly twofold more susceptible to the tested quinolones than the mgrA mutant. |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.